KTTA
NASDAQ · Biotechnology
Pasithea Therapeutics Corp
$0.52
-0.01 (-2.27%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+5,077.9% upside
Low Target
$19.73
Average Target
$26.92
High Target
$29.00
Current Price
$0.52
Current
$0.52
$0.52
Target
$26.92
$26.92
$19.73
$26.92 avg
$29.00
Scenario Analysis
Bear Case
$19.73
3,695.0%
Low target
Base Case
$26.92
+5,077.9%
Avg target
Bull Case
$29.00
+5,478.0%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$2.06
-74.8% from high
52-Week Low
$0.28
+85.0% from low
Target vs 52W High
$26.92
+1,206.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |